Northern Trust
LENZ

Northern Trust’s LENZ Therapeutics LENZ Stock Holding History

Northern Trust’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
187,144
+1,520
+0.8% +$12.3K ﹤0.01% 3441
2026
Q1 		$1.7M Buy
185,624
+23,713
+15% +$333K ﹤0.01% 3060
2025
Q4 		$2.59M Sell
161,911
-3,368
-2% -$98.2K ﹤0.01% 2843
2025
Q3 		$7.7M Sell
165,279
-5,457
-3% -$201K ﹤0.01% 2261
2025
Q2 		$5M Buy
170,736
+29,782
+21% +$810K ﹤0.01% 2458
2025
Q1 		$3.62M Buy
140,954
+1,666
+1% +$41K ﹤0.01% 2594
2024
Q4 		$4.02M Buy
139,288
+9,649
+7% +$294K ﹤0.01% 2634
2024
Q3 		$3.08M Buy
129,639
+48,170
+59% +$1.07M ﹤0.01% 2735
2024
Q2 		$1.41M Buy
81,469
+40,830
+100% +$713K ﹤0.01% 3087
2024
Q1 		$907K Buy
40,639
+754
+2% +$15.7K ﹤0.01% 3354
2023
Q4 		$731K Buy
39,885
+4,825
+14% +$79.7K ﹤0.01% 3422
2023
Q3 		$609K Sell
35,060
-788
-2% -$13.7K ﹤0.01% 3461
2023
Q2 		$652K Buy
35,848
+25,392
+243% +$507K ﹤0.01% 3477
2023
Q1 		$179K Sell
10,456
-792
-7% -$12.8K ﹤0.01% 3903
2022
Q4 		$261K Buy
11,248
+2,235
+25% +$51.8K ﹤0.01% 3740
2022
Q3 		$200K Buy
9,013
+2,075
+30% +$49.4K ﹤0.01% 3875
2022
Q2 		$134K Sell
6,938
-28,307
-80% -$631K ﹤0.01% 4062
2022
Q1 		$1.26M Buy
35,245
+11,614
+49% +$727K ﹤0.01% 3319
2021
Q4 		$2.06M Buy
23,631
+3,174
+16% +$263K ﹤0.01% 3211
2021
Q3 		$2.35M Buy
+20,457
New +$3.03M ﹤0.01% 3203

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Northern Trust's LENZ Position: Q2 2026 in Review

Northern Trust increased its LENZ Therapeutics (LENZ) stake by 0.82% in Q2 2026, buying an estimated $12.3K and bringing the position to 187,144 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

Northern Trust first reported a position in LENZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $7.7M in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Northern Trust held 187,144 shares of LENZ Therapeutics worth $1.06M as of Q2 2026.
  • Northern Trust bought 1,520 LENZ Therapeutics shares in Q2 2026, an estimated $12.3K.
  • LENZ Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3441 holding.
  • Northern Trust first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's LENZ Therapeutics position peaked at $7.7M in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.